The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Oscar Health is the larger company, worth $10.4B, about 4.2 times Clover Health Investments.
  • Clover Health Investments grew revenue faster over the last year (+55.6% vs -6.2%).
  • Oscar Health keeps more of each dollar of revenue as operating profit (2128.9% vs -0.7%).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureCLOVOSCR
Market cap$2.5B$10.4B
Share price$4.79$33.37
Revenue (last fiscal year)$1.9B$29M
Free cash flow (last fiscal year)-$69M$1.1B
Revenue growth, last year+55.6%-6.2%
Revenue growth per year, last 5 fiscal years+6.9%+51.7%
Operating margin-0.74%2128.9%
Net margin-0.74%1861.9%
Return on equity-4.9%26.8%
P/E (trailing)——
Price / free cash flow—9.86x
EV / EBITDA—9.58x
FCF growth the price implies—-4.4%
Dividend yield——
Debt / equity0.91x4.47x
Fundamental gradeDC
Superinvestors holding it12
Insider purchases, last 12 months01

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Clover Health Investments

YearRevenueFree cash flowOp. margin
2021$1.5B-$283M-43.3%
2022$1.1B-$208M-26.1%
2023$1.3B-$145M-16.3%
2024$1.4B$33M-3.3%
2025$1.9B-$69M-4.4%

Oscar Health

YearRevenueFree cash flowOp. margin
2021$5M-$208M-10094.2%
2022$65M$351M-908.5%
2023$21M-$298M-1103.4%
2024$21M$950M278.3%
2025$29M$1.1B-1386.2%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CLOV in Investingly

Questions

Which is bigger, Clover Health Investments or Oscar Health?

Oscar Health (OSCR), at $10.4B against $2.5B.

Which grows faster, CLOV or OSCR?

Clover Health Investments: revenue grew +55.6% over the last year, against -6.2%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.